Unity Biotechnology, Inc.
UBXDelisted Aug 6, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001463361
Unity Biotechnology, Inc. was delisted on Aug 6, 2025; its insiders filed their last Form 4 on Apr 3, 2025; 35 institutions reported holding it in 13F filings for Q2 2025, worth $987.3K in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Unity Biotechnology, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −4 vs. Q2 2023
- Shares held
- 2.68M
- −19.8K (−0.7%) vs. Q2 2023
- Total value
- $6.42M
- −$452.3K (−6.6%) vs. Q2 2023
- New holders
- 4
- 6 more added
- Sold out
- 8
- 9 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting UBX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 6 | $1.68K |
| Q2 2025 | 35 | $987.3K |
| Q1 2025 | 40 | $2.95M |
| Q4 2024 | 37 | $3.10M |
| Q3 2024 | 38 | $5.09M |
| Q2 2024 | 39 | $4.66M |
| Q1 2024 | 40 | $5.87M |
| Q4 2023 | 42 | $8.33M |
| Q3 2023 | 36 | $6.42M |
| Q2 2023 | 40 | $6.87M |
| Q1 2023 | 46 | $5.13M |
| Q4 2022 | 54 | $12.6M |
| Q3 2022 | 72 | $24.1M |
| Q2 2022 | 66 | $5.31M |
| Q1 2022 | 71 | $14.2M |
| Q4 2021 | 72 | $21.3M |
| Q3 2021 | 84 | $42.1M |
| Q2 2021 | 98 | $84.0M |
| Q1 2021 | 92 | $121.8M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Unity Biotechnology, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Qube Research & Technologies Ltd | 18 | $43 | 0.00% | +18 | New |
| AllSquare Wealth Management LLC | 55 | $132 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 90 | $216 | 0.00% | +84+1,400.0% | Added |
| Ameritas Investment Partners, Inc. | 100 | $240 | 0.00% | 00.0% | Unchanged |
| Carmichael Hill & Associates, Inc. | 100 | $240 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 129 | $309 | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 200 | $480 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 200 | $480 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 251 | $602 | 0.00% | −552−68.7% | Reduced |
| UBS Group AG | 360 | $864 | 0.00% | +350+3,500.0% | Added |
| Johnson Midwest Financial, LLC | 661 | $1.59K | 0.00% | 00.0% | Unchanged |
| Glen Eagle Advisors, LLC | 1,104 | $2.65K | 0.00% | −1−0.1% | Reduced |
| Royal Bank of Canada | 1,914 | $4.00K | 0.00% | +1,794+1,495.0% | Added |
| CIBC Asset Management Inc | 10,634 | $25.5K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 17,095 | $41.0K | 0.00% | +17,095 | New |
| Susquehanna International Group, LLP | 19,181 | $46.0K | 0.00% | +19,181 | New |
| Northern Trust Corp | 21,638 | $51.9K | 0.00% | −1,064−4.7% | Reduced |
| Advisor Group Holdings, Inc. | 23,116 | $55.5K | 0.00% | +8,705+60.4% | Added |
| Commonwealth Equity Services, LLC | 24,362 | $58.0K | 0.00% | −100.0% | Reduced |
| Morgan Stanley | 30,646 | $73.6K | 0.00% | −15,768−34.0% | Reduced |
| State Street Corp | 37,824 | $90.8K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 38,371 | $92.0K | 0.00% | −4,100−9.7% | Reduced |
| Alyeska Investment Group, L.P. | 38,695 | $92.9K | 0.00% | +38,695 | New |
| Dimensional Fund Advisors LP | 39,719 | $95.3K | 0.00% | −21,228−34.8% | Reduced |
| Cercano Management LLC | 41,238 | $99.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 43,499 | $104.4K | 0.00% | +20.0% | Added |
| Founders Fund V Management, LLC | 49,172 | $118.0K | 14.70% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 50,000 | $120.0K | 0.00% | 00.0% | Unchanged |
| Laurion Capital Management LP | 70,000 | $168.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 113,457 | $272.3K | 0.00% | −1,389−1.2% | Reduced |
| Mayo Clinic | 124,081 | $297.8K | 0.57% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 131,782 | $316.4K | 0.00% | +5,674+4.5% | Added |
| UBS Oconnor LLC | 179,080 | $429.8K | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 561,602 | $1.35M | 0.00% | −1,356−0.2% | Reduced |
| ARCH Venture Management, LLC | 1,004,817 | $2.41M | 1.57% | 00.0% | Unchanged |
| TSFG, LLC | 50 | – | – | 00.0% | Unchanged |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −21,500−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −17,949−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −13,160−100.0% | Sold out |
| Prime Capital Investment Advisors, LLC | 0 | $0 | 0.00% | −11,420−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −1,673−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −45−100.0% | Sold out |
| WealthPLAN Partners, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |